NCT02981082View on ClinicalTrials.gov

Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

PHASE1TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

February 10, 2020

Study Completion Date

February 10, 2020

Conditions
Systemic SclerosisPulmonary; Hypertension
Interventions
DRUG

Dimethyl Fumarate (DMF)

Dimethyl Fumarate (DMF) is a prescription medicine used to treat relapsing multiple sclerosis.

DRUG

Placebo Oral Tablet

Sugar pill manufactured to mimic Dimethyl Fumarate (DMF)

Trial Locations (4)

15213

University of Pittsburgh, Pittsburgh

21205

John Hopkins, Baltimore

80206

National Jewish, Denver

02118

Boston University, Boston

Sponsors

Collaborators (1)

Biogen
All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

Robert Lafyatis

OTHER